The effect of smoking on long-term gray matter atrophy and clinical disability in patients with relapsing-remitting multiple sclerosis
IA Lie, K Wesnes, SS Kvistad, I Brouwer… - Neurology …, 2022 - AAN Enterprises
Background and Objectives The relationship between smoking, long-term brain atrophy, and
clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed long …
clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed long …
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
IA Lie, S Kaçar, K Wesnes, I Brouwer… - Journal of Neurology …, 2022 - jnnp.bmj.com
Background The predictive value of serum neurofilament light chain (sNfL) on long-term
prognosis in multiple sclerosis (MS) is still unclear. Objective Investigate the relation …
prognosis in multiple sclerosis (MS) is still unclear. Objective Investigate the relation …
[HTML][HTML] Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis
K Wesnes, KM Myhr, T Riise, SS Kvistad… - Multiple Sclerosis and …, 2021 - Elsevier
Background Low vitamin D levels, tobacco use and high body mass index (BMI) have been
linked to adverse disease outcomes in multiple sclerosis (MS), but their influence on long …
linked to adverse disease outcomes in multiple sclerosis (MS), but their influence on long …